On October 13, 2018, Mr. Wang Zhihou, the secretary of the Tonghua Municipal Committee, accompanied by Mr. Zhang Jishun, secretary of the Huinan County Committee of Tonghua City, as well as other government entourages, came and visited Jilin Deshang Pharmaceutical Co., Ltd.
Mr. Wang Zhihou and his entourage visited the R&D center firstly. Mr. Tang Baozhong, GM of Deshang, introduced the status and expected launched date of our 8 under-developing products: Quetiapine Fumarate sustained-release tablets, Calcium carbonate D3 granules, Adenosine butyldisulfonate methionine enteric-coated tablets, Chloroglyprin Bisulfate enteric-coated tablet, Paroxetine Hydrochloride enteric-coated sustained-release tablets, Lamotrigine dispersible tablets, and Olmesartan amlodipine tablets. Mr. Wang and other accompanies and our R&D leader - Ms. Wang Juan had made a detailed communication during the visit.
After the introduction of under-developing products, Mr. Wang Zhihou praised to the hard work of our R&D team. He pointed out that the R&D capability is the driving force behind the development of pharmaceutical companies. He also pointed that Deshang should continue to expanding R&D of new drugs, attracted and retained talents by innovation and company.
After then, Mr. Wang Zhihou and other delegations visited our new factory - Detai Pharmaceutical. Mr. Tang Baozhong introduced the layout of the plant and schedules of the project, and told that it is expected to be launched for production by October, 2019.
At the end, Mr. Wang Zhihou concluded that the development plan of Deshang reflects the scientific concept of enterprise development, and demonstrates case for all the enterprises in Tonghua City in the conversion of new and old kinetic energy. He hope that Deshang will become one of the leading companies of development, production and sales in Tonghua.
All the Local governments will make effort to provide protecting policies and support for Deshang, and escort for the development and growth of Deshang.